Form 4: Chemours Co Director Mary B. Cranston Reports Acquisition of 14,096 Shares
SEC Form 4 Filing
Director Mary B. Cranston reports acquiring 14,096 shares of Chemours Co common stock at $0 per share on April 22, 2025, bringing her total holdings to 100,539.8505 shares.
Summary
- On April 22, 2025, Mary B. Cranston, a director of Chemours Co, acquired 14,096 shares of common stock.
- The acquisition was made at a price of $0 per share.
- Following the transaction, Cranston's total beneficial ownership in Chemours Co amounts to 100,539.8505 shares.
- The transaction was reported on a Form 4 filing with the SEC.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, so the sentiment is neutral.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company insiders.
Stakeholder Impact
- The transaction may have a minor impact on shareholder sentiment, as it reflects a director's investment in the company.
Key Dates
| Date | Description |
|---|---|
| 04/22/2025 | Date of transaction: Mary B. Cranston acquired 14,096 shares of Chemours Co common stock. |
| 04/24/2025 | Date of report: Form 4 filing signed by Eric Stein, Attorney-in-Fact, on behalf of Mary B. Cranston. |
Keywords
Form 4, Beneficial Ownership, Director, Chemours Co, CC, Mary B. Cranston, Acquisition, Shares, SEC
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.